Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastro-intestinal Stromal Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00764595
What this trial is testing

Imatinib Mesylate in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal TumorMetastatic Cancer
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 5
Early research (Phase 1)Study completedNCT02571036
What this trial is testing

A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies

Who this might be right for
Gastrointestinal Stromal TumorsAdvanced Systemic MastocytosisAdvanced Cancers
Deciphera Pharmaceuticals, LLC 282
Large-scale testing (Phase 3)UnknownNCT02847429
What this trial is testing

Randomized Trial of Crenolanib in Subjects With D842V Mutated GIST

Who this might be right for
GIST With D842V Mutated PDGFRA Gene
Arog Pharmaceuticals, Inc. 120
Early research (Phase 1)Ended earlyNCT02185937
What this trial is testing

Influence of an Acidic Beverage on the Imatinib Exposure After Major Gastrectomy

Who this might be right for
Gastrointestinal Stromal TumorMajor Gastrectomy
Radboud University Medical Center 5
Testing effectiveness (Phase 2)Study completedNCT01396148
What this trial is testing

Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal Tumors
Pfizer 6
Not applicableActive Not RecruitingNCT04584008
What this trial is testing

Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics

Who this might be right for
Biliary Tract NeoplasmsGastric CancerEsophageal Squamous Cell Carcinoma+6 more
Peking University 600
Not applicableStudy completedNCT04476082
What this trial is testing

Nutrition in Gastrointestinal Tumors

Who this might be right for
Pancreatic CancerOesophageal CancerColon Cancer+7 more
University Medicine Greifswald 66
Not applicableUnknownNCT04927260
What this trial is testing

French Long Term Registry With Longitudinal Follow up of PDGFRA D842V-GIST Patients

Who this might be right for
GISTGIST, MalignantPDGFR-Alpha D842V
Centre Leon Berard 25
Testing effectiveness (Phase 2)Study completedNCT00718562
What this trial is testing

Efficacy and Safety of AMN107 in Patients With GastroIntestinal Stromal Tumors (GIST) Who Have Failed Both Imatinib and Sunitinib

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 35
Testing effectiveness (Phase 2)Looking for participantsNCT05957367
What this trial is testing

Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies

Who this might be right for
GIST
Deciphera Pharmaceuticals, LLC 94
Testing effectiveness (Phase 2)Looking for participantsNCT06630234
What this trial is testing

A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Stromal Tumor (GIST)
Deciphera Pharmaceuticals, LLC 120
Not applicableStudy completedNCT03963544
What this trial is testing

Patterns of Care and Outcomes of Patients With METAstatic Gastrointestinal Stromal Tumors (METAGIST)

Who this might be right for
Gastro Intestinal Stromal Tumor
Institut Bergonié 492
Not applicableStudy completedNCT07614841
What this trial is testing

To Explore the Optimal Therapeutic Window for Imatinib in the Adjuvant Treatment of Intermediate and High-risk Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumors (GISTs)
First Affiliated Hospital, Sun Yat-Sen University 328
Not applicableApproved For MarketingNCT00094029
What this trial is testing

A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248

Who this might be right for
Gastrointestinal Neoplasm
Pfizer
Testing effectiveness (Phase 2)Study completedNCT00237172
What this trial is testing

Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study)

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 72
Not applicableStudy completedNCT05381753
What this trial is testing

Safety and Efficacy of Avapritinib in Chinese Patients With Gastrointestinal Stromal Tumor (GIST) in the Real World

Who this might be right for
Gastrointestinal Stromal Tumors
CStone Pharmaceuticals 61
Large-scale testing (Phase 3)Study completedNCT01462994
What this trial is testing

Detection of CF-DNA in Patients With Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
Gastrointestinal Stromal Tumors
Technical University of Munich 25
Testing effectiveness (Phase 2)WithdrawnNCT01270893
What this trial is testing

Tasigna Neoadjuvant Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Cancer
M.D. Anderson Cancer Center
Not applicableStudy completedNCT01114087
What this trial is testing

Impact of the Inhibitors of Tyrosine Kinase on the Male Fertility

Who this might be right for
Chronic Myeloid LeukemiaGastrointestinal Stromal Tumors
Assistance Publique - Hôpitaux de Paris 2
Early research (Phase 1)Study completedNCT02508532
What this trial is testing

(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors

Who this might be right for
Gastrointestinal Stromal Tumors (GIST)Other Relapsed or Refractory Solid Tumors
Blueprint Medicines Corporation 250
Next Page